« Back to Record
Manceau, G., Imbeaud, S., Thiébaut, R., Liébaert, F., Fontaine, K., Rousseau, F., Génin, B., Le Corre, D., Didelot, A., Vincent, M., Bachet, J.-B., Chibaudel, B., Bouché, O., Landi, B., Bibeau, F., Leroy, K., Pénault-Llorca, F., Van Laethem, J.-L., Demetter, P., Tejpar, S., Rossi, S., Mosakhani, N., Osterlund, P., Ristamäki, R., Sarhadi, V., Knuutila, S., Boige, V., André, T., & Laurent-Puig, P. (2014). Hsa-miR-31-3p expression is linked to progression-free survival in patients with KRAS wild-type metastatic colorectal cancer treated with anti-EGFR therapy. Clinical cancer research, 20(12), 3338-3347. doi:10.1158/1078-0432.CCR-13-2750
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/186441



